Future research should focus on validating FCGR3A’s role in vivo assays to confirm its utility as a therapeutic target and investigating the precise mechanisms of FCGR3A in M2 macrophage infiltration and its impact on tumor progression will be crucial for translating these findings into clinical practice. Here, FCGR3A is linked to neoplasm.